Back

Left ventricular anterolateral site is the preferable left ventricular lead position for an upgrade to biventricular pacing

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: New insights into cardiac resynchronisation therapy and remote monitoring Cardiac Resynchronisation Therapy (CRT) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Michio Ogano

Shizuoka Medical Center, Shizuoka (Japan)

6 More presentations in this session

Presentation thumbnail
Biventricular or conduction system pacing for cardiac resynchronization therapy: a proposed treatment algorithm based on interventricular conduction delays
Doctor F. Landra (Cuneo, IT)
Abstract Slides Video
Presentation thumbnail
Associations of 2013 and 2021 ESC definitions of left bundle-branch block with mechanical dyssynchrony and CRT-induced reverse remodeling
Doctor A. Beela (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Female gender is an independent predictor of clinical benefit from cardiac resynchronisation therapy - results from the BIOWOMEN study
Doctor L. Van Erven (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Personalized cardiac resynchronization therapy guided by real-time electrocardiographic imaging for non-left bundle branch block patients
Doctor M. Tam (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Fragmented QRS complex as a predictor of all-cause mortality in patients undergoing cardiac resynchronization therapy
Doctor J. Esteban Chapel (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
New insights into cardiac resynchronisation therapy and remote monitoring

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Conduction system pacing in the current treatment of HFrEF patients
thumbnail
Congress Presentation
Device therapy: how to identify responders?
thumbnail
Congress Presentation
Cardiac resynchronisation therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources